Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accomplish, Affymetrix, Agilent, agnostic, amplification, art, aspect, AstraZeneca, augmented, back, Baldwin, blue, bodily, certainty, circumvention, classification, COLD, competitor, correctly, correlate, dedicated, defense, dialog, digital, displayed, distraction, divested, domain, double, dramatically, droplet, earliest, easily, easy, elapse, error, exceeding, fall, fastest, fax, feasible, fluid, fold, forefront, frequency, friendly, fruit, Gen, GlaxoSmithKline, greatly, highest, Horizon, IDT, Ineffective, influential, infrastructure, Iona, jeopardized, John, lapse, learn, legacy, Leigh, Leon, longevity, Luther, maker, MDx, Melbourne, mentioned, menu, Michael, middle, monetization, multiplexed, Multiplexing, NGS, Notably, Obama, ordinary, overriding, painful, partnership, plc, precision, premier, prevalence, printing, promised, proof, publishing, Raptor, readily, reality, reconciliation, recruited, redeploying, regimen, remediate, remediated, remote, resigned, scrutiny, secret, shed, showing, sky, slight, spite, spur, sputum, Squibb, stage, statute, step, strategist, stratification, sublicensed, suppressing, sustain, Thermo, Thompson, tier, unbilled, understood, underutilized, underway, Underwriter, undetected, uniform, unlimited, unsecured, uplisting, urine, user, visibility, Waring
Removed:
acted, addressing, aid, antibody, assist, assure, award, binomial, body, calculation, call, cap, cardiovascular, cell, clopidogrel, closure, combined, compel, consolidate, Craig, cultivate, decision, deficit, demonstrated, distributor, DNASEP, Doit, driven, effort, Ernst, exploitation, face, FC, field, force, formula, function, Gaithersburg, Gamma, gene, hold, interpolation, involving, joining, Koppler, lab, lack, larger, lieu, linear, LLP, marketability, Maryland, matched, melanoma, monoclonal, mtDNA, NE, NuclearMitome, OLIGOSEP, operational, OPTIMASE, OPTIMIZED, panel, participated, pathway, Patzig, pharmacological, plasma, Plavix, promotion, recapitalization, receiving, receptor, regionally, revaluation, RNASEP, Robert, Scan, secured, selection, serum, shift, shortage, sought, stop, Stratagene, strike, strong, susceptibility, Tuttle, WAVEMAKER, workforce, Young
Filing tables
Filing exhibits
Related press release
PRPO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 No’s 333-41714, 333-69334, 333-139999 and 333-196712) of Transgenomic, Inc. of our report dated April 15, 2015, with respect to the consolidated financial statements of Transgenomic, Inc. and Subsidiary included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
Hartford, Connecticut
April 15, 2015